Implantation of engineered adipocytes suppresses tumor progression in cancer models is a research paper published in Nature Biotechnology (2025). On theSindex it has a DataRank of 0.550. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: 1R01CA283826
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: 1P50CA168504
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK124769
California Institute for Regenerative Medicine
Grant: EDUC4-12812
California Institute for Regenerative Medicine
Grant: SFSU EDUC2-12693
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Grant: 1K99HG012576
NCI NIH HHS
Grant: P50 CA168504
NIDDK NIH HHS
Grant: R01 DK124769
NHGRI NIH HHS
Grant: K99 HG012576
NCI NIH HHS
Grant: R01 CA283826
NCI NIH HHS
Grant: R01 CA292019
NCI NIH HHS
Grant: R01 CA281361
National Institutes of Health
Grant: 1K99HG012576-01
Development of functional genomic technologies in mice
National Institutes of Health
Grant: 5R01CA283826-02
Bioengineering adipocytes for cancer therapy
National Institutes of Health
Grant: 5R01DK124769-04
From Obesity GWAS to therapeutic targets
National Institutes of Health
Grant: 5R01CA292019-02
Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells
National Institutes of Health
Grant: 5P50CA168504-03
Overcoming Resistance to Standard HER2-Directed Therapies for Breast Cancer
Susan G. Komen
METAvivor
FWCI
18.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals